8-K: Healthpeak Properties Announces Q4 and Full-Year 2023 Results, Merger with Physicians Realty Trust Progresses

Healthpeak Properties reported its fourth quarter and full-year 2023 financial results, highlighted by solid same-store NOI growth and progress on its merger with Physicians Realty Trust.

Summary

• Healthpeak Properties announced its financial results for the fourth quarter and full year ended December 31, 2023.
• The company reported a net income of $0.13 per share for the fourth quarter and $0.56 per share for the full year.
• Nareit FFO was $0.48 per share for the quarter and $1.79 per share for the year.
• Same-store portfolio cash NOI grew by 3.6% in the fourth quarter and 4.8% for the full year.
• The company executed 1.1 million square feet of new and renewal leases in the fourth quarter, including 743,000 square feet in outpatient medical and 312,000 square feet in lab space.
• Healthpeak completed several development projects, including the Nexus on Grand and Vantage lab buildings, and commenced two new outpatient developments with HCA Healthcare.
• A new $236 million joint venture was formed through the sale of a 65% interest in the Callan Ridge lab campus.
• The merger with Physicians Realty Trust is expected to close on March 1, 2024, pending shareholder approvals.
• Healthpeak expects to enter into a new $750 million 5-year unsecured term loan to fund the merger and for general corporate purposes.
• The company has established a 2024 outlook, including diluted earnings per share of $0.07 to $0.13 and diluted Nareit FFO per share of $1.54 to $1.60, inclusive of the merger impact.

Sentiment

Score: 7

Explanation: The document presents a generally positive outlook with solid operational results and progress on a strategic merger. However, there are some negative aspects such as the decrease in net income per share and the write-off of straight-line rent receivable. The forward-looking statements are cautiously optimistic.

Positives

• Healthpeak achieved solid same-store NOI growth, indicating strong operational performance.
• The company successfully executed significant new and renewal leases, demonstrating demand for its properties.
• The receipt of entitlements for additional lab development at the Vantage campus enhances future growth potential.
• The formation of the Callan Ridge joint venture provides capital and reduces future tenant improvement funding.
• The merger with Physicians Realty Trust is progressing as planned, which is expected to create a larger and more diversified healthcare REIT.
• Healthpeak's sustainability efforts have been recognized with multiple awards and inclusions in sustainability indices.
• The company has a strong development pipeline with several projects completed and new ones commenced.

Negatives

• Net income per share decreased from $0.92 in 2022 to $0.56 in 2023.
• The company incurred transaction and merger-related costs of $14.4 million in the fourth quarter.
• There was a write-off of $8.7 million of straight-line rent receivable associated with Sorrento Therapeutics, Inc.

Risks

• The merger with Physicians Realty Trust is subject to shareholder approvals and customary closing conditions, which may not be met.
• The integration of the two companies may present challenges and may not achieve the anticipated synergies.
• The company is exposed to macroeconomic trends, including inflation and interest rate changes.
• There are risks associated with the development, redevelopment, and tenant improvement projects, including potential delays and lower profits.
• The company's concentration in the healthcare property sector makes it vulnerable to downturns in that specific sector.
• The company is subject to various regulatory and compliance risks, including environmental and healthcare regulations.
• There are risks associated with joint ventures and unconsolidated entities, including reliance on partners' financial condition and cooperation.

Future Outlook

For full year 2024, Healthpeak has established an outlook inclusive of the impact from the Physicians Realty Trust merger, with diluted earnings per common share of $0.07 to $0.13, diluted Nareit FFO per share of $1.54 to $1.60, diluted FFO as Adjusted per share of $1.73 to $1.79, diluted AFFO per share of $1.50 to $1.56, and total portfolio same-store cash (adjusted) NOI growth of 2.25% to 3.75%.

Management Comments

• Management believes that FFO as Adjusted provides a meaningful supplemental measurement of our FFO run-rate and is frequently used by analysts, investors, and other interested parties in the evaluation of our performance as a REIT.
• Management utilizes its share of NOI and Adjusted NOI in assessing its performance as we have various joint ventures that contribute to its performance.

Industry Context

This announcement reflects the ongoing trend of consolidation in the healthcare REIT sector, with Healthpeak's merger with Physicians Realty Trust being a significant example. The focus on lab and outpatient medical properties aligns with the growing demand for these types of healthcare facilities. The company's sustainability efforts also reflect an increasing emphasis on ESG factors in the real estate industry.

Comparison to Industry Standards

• Healthpeak's same-store NOI growth of 4.8% for the full year is solid, but it is important to compare this to peers such as Ventas (VTR) and Welltower (WELL), which also operate in the healthcare REIT space.
• The 5.3% capitalization rate on the Callan Ridge joint venture is within the typical range for high-quality lab properties in the San Diego market, but it is important to compare this to recent transactions by Alexandria Real Estate Equities (ARE) and BioMed Realty.
• The blended yield of 5.35% on the senior unsecured notes is comparable to recent debt issuances by other REITs with similar credit ratings, but it is important to monitor the impact of rising interest rates on future financing costs.
• The company's development pipeline, including the Vantage campus and HCA outpatient developments, is consistent with the strategies of other healthcare REITs focused on modernizing and expanding their portfolios.

Stakeholder Impact

• Shareholders will be impacted by the merger with Physicians Realty Trust and the new term loan.
• Employees may be affected by the integration of the two companies.
• Tenants will benefit from the continued investment in high-quality healthcare properties.
• Creditors will be impacted by the new term loan and the repayment of existing debt.

Next Steps

• Healthpeak will hold a conference call and webcast on February 9, 2024, to discuss the results.
• The company will seek shareholder approval for the merger with Physicians Realty Trust on February 21, 2024.
• The merger with Physicians Realty Trust is expected to close on March 1, 2024.
• Healthpeak will enter into a new $750 million 5-year unsecured term loan.

Key Dates

Keywords

Healthpeak Properties, REIT, Healthcare Real Estate, Merger, Physicians Realty Trust, Lab Space, Outpatient Medical, Same-Store NOI, Development, Leasing, Joint Venture, Financial Results